Thus, it is highly possible that hepatic steatosis phenotype in HFD-fed RORαLKO mice may be resulted from both upregulated PPARγ activation and suppressed PPARα transcriptional activity in the absence of RORα. This evidence concerns the gene PPARG and fatty liver disease.